Prime Medicine PRME Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's common stock, shares issued (in shares)?
- Prime Medicine (PRME) reported common stock, shares issued (in shares) of $180.62M in Q1 2026.
- How has Prime Medicine's common stock, shares issued (in shares) changed year-over-year?
- Prime Medicine's common stock, shares issued (in shares) increased by 37.7% year-over-year, from $131.16M to $180.62M.
- What is the long-term trend for Prime Medicine's common stock, shares issued (in shares)?
- Over 4 years (2021 to 2025), Prime Medicine's common stock, shares issued (in shares) has grown at a 53.6% compound annual growth rate (CAGR), from $32.41M to $180.51M.